ALLR - Allarity Therapeutics Inc


1.26
-0.010   -0.794%

Share volume: 181,493
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%

$1.27
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
38%
Profitability 35%
Dept financing 32%
Liquidity 49%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
1.61%
1 Month
49.06%
3 Months
10.53%
6 Months
-24.10%
1 Year
23.53%
2 Year
224.07%
Key data
Stock price
$1.26
P/E Ratio 
0.00
DAY RANGE
$1.21 - $1.30
EPS 
-$8.26
52 WEEK RANGE
$0.61 - $2.35
52 WEEK CHANGE
$39.55
MARKET CAP 
24.983 M
YIELD 
N/A
SHARES OUTSTANDING 
15.812 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.90
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$274,327
AVERAGE 30 VOLUME 
$199,450
Company detail
CEO: James G. Cullem
Region: US
Website: allarity.com
Employees: 10
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

N/A

Recent news